After a meal, GLP-1 signals the pancreas to release insulin, helping lower blood sugar levels
They can also help enhance the absorption of key nutrients and support long-term health
UNICEF highlights that over 340 million children and adolescents aged 519 are overweight or obese, while chronic disease burden continues rising globally, encouraging development of improved long-acting and patient-friendly drug formulations to enhance treatment adherence and long-term outcomes
Patients with high-sensitivity genetic profiles may benefit from the Microdose GLP-1 Protocol or slower titration schedules, while those with robust receptor tolerance can advance more aggressively
It is available in a generic formulation as well as under different brand names, including empagliflozin
Capsules are stable at room temperature for several months when kept in a cool, dry place away from direct light